MSN Laboratories` Generic Fluphenazine Decanoate Receives Approval in the U.S.
Fluphenazine decanoate 25mg/1ml and 100mg/1ml solutions for injection ampoules (Modecate and Modecate Concentrate) manufactured by Sanofi, have been discontinued for some time and stock of any remaining batches will now have expired. Prescribers should complete arrangements to transfer patients on Modecate to therapeutic alternatives under medical supervision. Fluphenazine injections are available as unlicensed imports and any prescriptions issued for these will need to be written correctly to ensure accurate reimbursement.
Enforcement Report - Week of December 11, 2019
Amlodipine and Valsartan Tablets, Glipizide Extended-Release Tablets, Dexamethasone Tablets, Argatroban Injection, Fluphenazine Decanoate Injection, Meropenem Injection, Mycophenolate Mofetil Injection, Levothyroxine Sodium Injection; Shire-NPS Pharmaceuticals, Inc. v. Par Pharmaceutical et al.
Aurobindo Pharma’s Generic Fluphenazine Decanoate Receives Approval In US
Enforcement Report - Week of April 12, 2017
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.